BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Catalyst Brief//FDA catalyst calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Catalyst Brief — FDA catalyst calendar
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:event-112@catalystbrief.girapphe.com
DTSTAMP:20261117T181549Z
LAST-MODIFIED:20261117T181549Z
DTSTART;VALUE=DATE:20261101
DTEND;VALUE=DATE:20261102
SUMMARY:Readout: Sanofi — Yellow fever vaccine (live) [Nov 2026]
DESCRIPTION:Phase 3 primary completion: A Phase III Control Study of the Sa
 fety and Immunogenicity of vYF in Pediatric Population.\nSource: https://c
 linicaltrials.gov/study/NCT07103148\nhttps://catalystbrief.girapphe.com/e/
 112?lang=en\nNot investment advice. Dates may change.
URL:https://catalystbrief.girapphe.com/e/112?lang=en
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
